Skin cancer combination therapy one step closer to EU approval

Skin cancer combination therapy one step closer to EU approval

25 Sep 2015

Roche is expecting the European Commission this year to issue a final decision on a drug combination to treat advanced skin cancer, based on the positive opinion issued on the product.

CareAcross-ampoules

The European Union's Committee for Medicinal Products for Human Use, or CHMP, has adopted a positive opinion for Cotellic, when used in combination with Zelboraf for treatment of patients with a type of metastatic melanoma, Roche declared.

Roche in August won approval for the drug combination in Switzerland and expects a final decision on approval in the United States this year.

Source: Reuters

Login to your account

Did you forget your password?